Zhejiang Hesenna Medicine Co., Ltd., the main body of the Group (hereinafter referred to as HSN), was established in Lishui City, Zhejiang Province in 2020. Based in China and facing the world, HSN is committed to building a pharmaceutical group that provides integrated services of commercialization, supply chain and brand promotion of foreign high-end patented drugs in China. Hesenna (Guangdong) Healthcare Consulting & Servicing Co., Ltd, a wholly-owned subsidiary of HSN, focuses on building professional, compliant and efficient commercial operation, which has established a professional brand image for many high-quality products.

The main business of HSN is the academic promotion of original drugs from top foreign companies in China, currently in the fields of oncology, osteoporosis and antivirals. HSN focuses on the in-depth academic development and promotion of products, meeting the needs of doctors and patients for drug services through the development of market academic promotion models, the establishment of advanced market academic platforms, effective planning and guidance, compliant operations, and a refined sales team. HSN strives to build a highly compliant pharmaceutical service enterprise, provide a sustainable development platform for partners, and provide a stage for fighters. HSN adheres to the principle of “people-oriented, happy work, healthy life”, evaluates employees and selects leaders with responsibility and contribution, and provides a good promotion platform for employees. High-quality products and management systems, perfect career planning, smooth promotion ladder and talent team construction enable employees to grow rapidly, and through personal efforts, gain reasonable returns and memorable life experiences. We are looking for proactive, self-driven talents, and HSN will be a platform for sincere cooperation and common development with you.